Strong work from @IMFmyeloma & #USMMImmunotherapyConsortium! @ZanwarSaurabh @End_myeloma @SurbhiSidanaMD @DrKrinaPatel Doris Hansen @DrRakeshPopat @szusmani @HiraSMian @TomMartinMD
#Myeloma Paper of the Day: CHARGE Prognostic Index (HRCAs, hyperferritinemia, anemia, early relapse (<18 mos from frontline), ECOG ≥2) & exposure to prior BCMA-directed tx) may identify RRMM pts at risk for early treatment failure w/ bispecifics: pubmed.ncbi.nlm.nih.gov/43024836/. #mmsmView quoted post on X